StockData
Callan JMB Inc. logo

Callan JMB Inc. (CJMB) company profile

CJMBNasdaqServices-Business Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3080% below fair value
$0.36−0.05 (-11.46%)

Close on Nov 17, 2026Market cap $2.07MP/E –Yield –

About Callan JMB

Services-Business Services, NEC, SIC 7389

Callan JMB Inc. provides temperature-controlled logistics, fulfillment, and monitoring services primarily for the life sciences sector. The company specializes in cold chain solutions for temperature-sensitive items such as biological materials, vaccines, and cell therapies. Its primary offerings include emergency preparedness and rapid response deployment, specialized reusable thermal packaging, fulfillment services, and proprietary predictive tracking technologies, including Sentry monitoring and Ship2Q inventory software. Callan JMB serves life sciences organizations, commercial healthcare clients, and public sector entities, including government agencies, the United Nations, and NATO.

The enterprise operates across major parts of the United States and Canada, maintaining a dispatch-capable service center infrastructure and licensing in multiple jurisdictions. It also holds an entity in Pune, India, with no active operations. Corporate headquarters are situated in Spring Branch, Texas.

Summary of the business section of Callan JMB's latest annual report, written by StockData.

Company profile

Company

Legal name
Callan JMB Inc.
Founded
2024
Headquarters
Spring Branch, TX
Address
244 Flightline Drive 78070
Phone
(830) 438-0395
Employees
20, Dec 31, 2025
Industry
Services-Business Services, NEC
Incorporated in
Nevada
Fiscal year ends
December 31
Auditor
Rosenberg Rich Baker Berman, P.A., Somerset, New Jersey

Stock & identifiers

Ticker
CJMB
Exchange
Nasdaq
IPO date
Feb 6, 2025
Shares outstanding
6M, Aug 12, 2026
Public float
$7.40M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
2032545
CUSIP
131100109
ISIN
US1311001093
FIGI
BBG01QK922X6
Share class FIGI
BBG01QK923R1
EIN
99-0931141

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Wayne D. WilliamsCEO, Chairman and President, Director2,377,468
Eric L. KashExecutive Vice President, Director–
David J. CroyleChief Medical Officer1,550,000
Jeffrey ApplemanChief Financial Officer–
Gerald DialDirector12,000
Liberty Smith DukeDirector1,512
Mark MellerDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Feb 6, 2025
Offer price
$4.00
Securities offered
1,280,000
Gross proceeds
$5.12M
Exchange
Nasdaq
First trading day
Feb 5, 2025
First-day close
$4.10+2.5%
Lock-up ends (est.)
Aug 4, 2025

“We are offering 1,280,000 shares of our common stock, par value $0.001 per share (“common stock”), at an initial public offering price of $4.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of the date of this report, we have 20 employees, of which 18 are full-time employees, and 2 are part-time or contractual/seasonal employees engaged on a seasonal and as-needed basis.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?